Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 12, 871-878, December 1, 1952]
© 1952 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Law, L. W.

Effects of Combinations of Antileukemic Agents on an Acute Lymphocytic Leukemia of Mice*

L. W. Law

( The National Cancer Institute, Bethesda, Md.{dagger})

An approach to the problem of chemotherapy of experimental leukemia, based upon knowledge of the mechanism of resistance, is presented.

The effects of several antileukemic compounds on survival time of mice bearing the acute lyphocytic leukemia, L 1210, have been studied. Striking potentiating effects were found in leukemic mice given A-methopterin and 8-azaguanine simultaneously. Alpha-peltatin and triethylene melamine did not significantly influence the effects of the two antimetabolites.

A-methopterin and 8-azaguanine given simultaneously in combination were more effective than the two compounds given singly in combination.

Thirty-five out of 320 mice given combinations of antileukemic compounds simultaneously survived 90 days or longer. These mice were apparently nonleukemic, and all those reinoculated with leukemic cells proved to be susceptible.

* Presented, in part, at the Gordon Research Conference, New London, N.H., August 30, 1951, and at the American Association for Cancer Research, Cleveland, Ohio, April 27–29, 1951.

{dagger} National Institutes of Health, U.S. Public Health Service.

Received 7/14/52.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1952 by the American Association for Cancer Research.